Vaccine Info

Coravax SARS-CoV-2 Vaccine

Coravax Description

Coravax SARS-CoV-2 Vaccine is made from a portion of the SARS-CoV-2 virus.  Utilizing the spike protein component of the virus, the vaccine will most likely generate a robust immune response.

Coravax similar to other vaccines uses a 'carrier' vaccine to deliver the vaccine. Coravax uses a killed rabies vaccine that has the spike protein as an added component.  An individual vaccinated with Coravax will develop antibodies for both SARS-CoV-2 as well as rabies.

Coravax Indication

CORAVAX is indicated for the prevention of the SARS-CoV-2 virus which causes COVID-19.

Coravax News

4/7/2020: Thomas Jefferson University researchers have a COVID-19 vaccine candidate that could cover a global need.  

5/20/2020: Bharat Biotech joins Thomas Jefferson University in pursuit of a SARS-CoV-2 vaccine

8/28/2020: $508,000 awarded to Thomas Jefferson University to support the development of Coravax

 

Updated
08/31/2020 - 09:09